斯里兰卡南部中度至重度斑块性牛皮患者的心血管风险:一项病例对照研究
Achala Liyanage1, Gayani Liyanage2, Binari Wijenayake3
1Dermatology, Faculty of Medicine, University of Ruhuna, Galle, LKA.
Cureus
|June 30, 2025
概括
患有慢性斑块牛皮的患者有增加的并发症和未调整的脂质水平,表明需要对患者进行全面评估. 医疗保健专业人员应采取整体方法来管理牛皮患者.
科学领域:
- 皮肤病学 皮肤病学
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,与心血管风险升高和并发症有关.
- 了解这些相关风险对于患者管理至关重要.
研究的目的:
- 评估慢性斑块牛皮 (CPP) 患者的心血管风险和促成因素.
- 为了比较CPP患者和匹配的对照组之间的心血管风险概况.
主要方法:
- 在斯里兰卡南部的一项病例控制研究,涉及80名CPP患者和80名对照患者.
- 通过问卷,人体测量和生化分析 (血糖,脂质) 收集的数据.
- 用弗雷明汉风险评分 (FRS) 和动脉样硬化心血管疾病 (ASCVD) 10年风险评分评估心血管风险; 查尔森伴随性疾病指数 (CCI) 的伴随性疾病.
主要成果:
- 与对照人群相比,牛皮患者的CCI得分更高,脂质失调的患病率更高.
- 在CPP患者中观察到高甘油和TG/HDL比率.
- 虽然牛皮群的心血管风险得分较高,但这种差异在统计学上并不显著.
结论:
- 患有CPP的患者表现出增加的并发症和未调整的脂质异常.
- 强调医疗保健专业人员需要实施针对CPP患者的整体评估策略.
相关概念视频
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
128
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
128
Atherosclerosis I: Introduction
93
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93
Coronary Artery Disease IV: Preventive Measures
39
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39
Psychoneuroimmunology: Cardiovascular Disease
82
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
82
Peripheral Artery Disease III: Interprofessional Care
33
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
33


